Bibliography
1 Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive
aspergillosis in patients admitted to the intensive care unit with
severe influenza: a retrospective cohort study. Lancet Respir Med.
2018;6(10):782-792.
2 Machado M, Valerio M, Álvarez-Uría A, et al. Invasive pulmonary
aspergillosis in the COVID-19 era: An expected new entity. Mycoses.
2021;64(2):132-143.
3 Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP. Outcomes
in Invasive Pulmonary Aspergillosis Infections Complicated by
Respiratory Viral Infections in Patients With Hematologic Malignancies:
A Case-Control Study [published correction appears in Open Forum
Infect Dis. 2019 Nov 25;6(11):ofz458]. Open Forum Infect Dis.
2019;6(7):ofz247.
4 Abbott JD, Fernando HV, Grulink K, Meade BW. Pulmonary aspergillosis
following post-influenzal bronchopneumonia treated with antibiotics. Br
Med J. 1952;1(4757):523-525
5 Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary
aspergillosis is a frequent complication of critically ill H1N1
patients: a retrospective study. Intensive Care Med.
2012;38(11):1761-1768.
6 Crum-Cianflone NF. Invasive Aspergillosis Associated With Severe
Influenza Infections. Open Forum Infect Dis. 2016;3(3):ofw171.
7 Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters
J. Invasive pulmonary aspergillosis complicating severe influenza:
epidemiology, diagnosis and treatment. Curr Opin Infect Dis.
2018;31(6):471-480.
8 Nulens EF, Bourgeois MJ, Reynders MB. Post-influenza aspergillosis, do
not underestimate influenza B. Infect Drug Resist. 2017;10:61-67.
9 Schwartz IS, Friedman DZP, Zapernick L, et al. High Rates of
Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be
Universal: A Retrospective Cohort Study from Alberta, Canada. Clin
Infect Dis. 2020;71(7):1760-1763.
10 Toda M, Benedict K, Jackson BR. Invasive Aspergillosis After
Influenza and Other Viral Respiratory Infections Among Intensive Care
Unit Patients in a Commercially Insured Population in the United States,
2013-2018. Open Forum Infect Dis. 2021;8(3):ofab091.
11 Thevissen K, Jacobs C, Holtappels M, Toda M, Verweij P, Wauters J.
International survey on influenza-associated pulmonary aspergillosis
(IAPA) in intensive care units: responses suggest low awareness and
potential underdiagnosis outside Europe [published correction appears
in Crit Care. 2020 Apr 29;24(1):186]. Crit Care. 2020;24(1):84.
12 Ku YH, Chan KS, Yang CC, Tan CK, Chuang YC, Yu WL. Higher mortality
of severe influenza patients with probable aspergillosis than those with
and without other coinfections. J Formos Med Assoc. 2017;116(9):660-670.
13 van de Veerdonk FL, Kolwijck E, Lestrade PP, et al.
Influenza-Associated Aspergillosis in Critically Ill Patients. Am J
Respir Crit Care Med. 2017;196(4):524-527.
14 Waldeck F, Boroli F, Suh N, et al. Influenza-associated aspergillosis
in critically-ill patients-a retrospective bicentric cohort study. Eur J
Clin Microbiol Infect Dis. 2020;39(10):1915-1923.
15 Vanderbeke L, Janssen NAF, Bergmans DCJJ, et al. Posaconazole for
prevention of invasive pulmonary aspergillosis in critically ill
influenza patients (POSA-FLU): a randomised, open-label,
proof-of-concept trial. Intensive Care Med. 2021;47(6):674-686.
16 Blot SI, Taccone FS, Van den Abeele AM, et al. A clinical algorithm
to diagnose invasive pulmonary aspergillosis in critically ill patients
[published correction appears in Am J Respir Crit Care Med. 2012 Oct
15;186(8):808]. Am J Respir Crit Care Med. 2012;186(1):56-64.
17 Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology
Score (SAPS II) based on a European/North American multicenter study
[published correction appears in JAMA 1994 May
4;271(17):1321]. JAMA. 1993;270(24):2957-2963.
18 ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute
respiratory distress syndrome: the Berlin Definition. JAMA.
2012;307(23):2526-2533.
19 Bernard GR, Artigas A, Brigham KL, et al. The American-European
Consensus Conference on ARDS. Definitions, mechanisms, relevant
outcomes, and clinical trial coordination. Am J Respir Crit Care Med.
1994;149(3 Pt 1):818-824.
20 Zwaans WA, Mallia P, van Winden ME, Rohde GG. The relevance of
respiratory viral infections in the exacerbations of chronic obstructive
pulmonary disease—a systematic review. J Clin Virol.
2014;61(2):181-188.
21 Zheng XY, Xu YJ, Guan WJ, Lin LF. Regional, age and
respiratory-secretion-specific prevalence of respiratory viruses
associated with asthma exacerbation: a literature review. Arch Virol.
2018;163(4):845-853.
22 Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a
risk factor for invasive aspergillosis in patients with lung
disease. Thorax. 1991;46(1):15-20.
23 Fraczek MG, Chishimba L, Niven RM, et al. Corticosteroid treatment is
associated with increased filamentous fungal burden in allergic fungal
disease. J Allergy Clin Immunol. 2018;142(2):407-414.
24 Gago S, Denning DW, Bowyer P. Pathophysiological aspects of
Aspergillus colonization in disease. Med Mycol.
2019;57(Supplement_2):S219-S227.
25 Bundesamt für Gesundheit und Eidgenössische Kommission für
Impffragen. Schweizerischer Impfplan 2021, (01/2021).
www.bag.admin.ch/impfplan.
26 Barberán J, García-Pérez FJ, Villena V, et al. Development of
Aspergillosis in a cohort of non-neutropenic, non-transplant patients
colonised by Aspergillus spp. BMC Infect Dis. 2017;17(1):34.
27 Tracy MC, Okorie CUA, Foley EA, Moss RB. Allergic Bronchopulmonary
Aspergillosis. J Fungi (Basel). 2016;2(2):17.
28 Shi C, Shan Q, Xia J, et al. Incidence, risk factors and mortality of
invasive pulmonary aspergillosis in patients with influenza: A
systematic review and meta-analysis. Mycoses. 2022;65(2):152-163.
29 Caini S, Kroneman M, Wiegers T, El Guerche-Séblain C, Paget J.
Clinical characteristics and severity of influenza infections by virus
type, subtype, and lineage: A systematic literature review. Influenza
Other Respir Viruses. 2018;12(6):780-792.
30 Minchole E, Figueredo AL, Omeñaca M, et al. Seasonal Influenza A
H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in
Non-Elderly, At-Risk People. PLoS One. 2016;11(11):e0165711.
31 Sharma Y, Horwood C, Hakendorf P, Thompson C. Clinical
characteristics and outcomes of influenza A and B virus infection in
adult Australian hospitalised patients. BMC Infect Dis. 2020;20(1):913.
32 Su S, Chaves SS, Perez A, et al. Comparing clinical characteristics
between hospitalized adults with laboratory-confirmed influenza A and B
virus infection. Clin Infect Dis. 2014;59(2):252-255.